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Mutations in Kir2.1 Cause the Developmental
and Episodic Electrical Phenotypes
of Andersen’s Syndrome
Summary
Andersen’s syndrome is characterized by periodic pa-
ralysis, cardiac arrhythmias, and dysmorphic features.
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Figure 1. Andersen’s Syndrome Is Charac-
terized by Dysmorphic Features, Cardiac Ar-
rhythmias, and Periodic Paralysis
(A and B) Andersen’s patient exhibiting low
set ears, hypertelorism, micrognathia, and (C)
clinodactyly of the fifth digits. (D) ECG rhythm
strip from an Andersen’s patient demonstra-
ting short runs of polymorphic ventricular
tachycardia. (E) Muscle biopsy of an Ander-
sen’s patient exhibiting tubular aggregates
commonly seen in periodic paralysis patients.
and some migraine conditions would be caused by mu- hypothesis (Tawil et al., 1994). Periodic paralysis has
been associated with mutations in voltage-gated K1, Na1,tations in homologous genes (Ptacek et al., 1991). Simi-
larities between these different episodic phenotypes Ca21, and Cl2 channels (Jen and Ptacek, 2001), while
LQT syndrome (LQTS) has been associated with muta-suggested similar molecular bases of these disorders.
The occurrence of both periodic paralysis and long QT tions in voltage-gated K1 and Na1 channels (Keating and
Sanguinetti, 2001). To date, no human disorders involv-(LQT) in Andersen’s syndrome strongly supported this
ing cardiac and skeletal muscle have been attributed to
mutations in inward rectifying K1 (Kir) channels.
In this report, we present extensive genetic and func-
tional data demonstrating that KCNJ2, encoding the in-
ward rectifying K1 channel Kir2.1, is a major Andersen’s
syndrome gene. We propose that dominant negative
mutations of Kir2.1 channel function are responsible for
the dysmorphic features, periodic paralysis, and cardiac
arrhythmias of AS. Importantly, mutations in Kir2.1 could
account for some unexplained cases of periodic paraly-
sis and cardiac arrhythmias. Not only does this study
help support the predictions that mutations in Kir chan-
nels cause episodic phenotypes, but it also supports the
role of this ion channel in providing developmental signals.
Results
Patients with Andersen’s Have Variable Expressivity
A total of 16 unrelated Andersen’s syndrome kindreds
were identified who met the defined diagnostic criteria
(see Experimental Procedures). Most kindreds were small,
consisting of one to three affected individuals. AffectedFigure 2. Pedigree of Kindred 4415 Exhibiting Variable Expressivity
individuals showed marked variability in the phenotypicand Associated KCNJ2 Mutation
expression of the disease. While some individuals, typi-(A) Females are denoted with circles and males with squares. An
cally including the index cases, manifested the full Ander-“*” denotes an individual that was not included in the genome-wide
linkage screen. sen’s triad (Figure 1), other affected individuals demon-
(B) Sequence chromatograph of an affected individual with an A to strated only one or two of the major characteristics of
T transversion corresponding to the D71V mutation. this disorder. Dysmorphic features ranged from negligi-
(C) Amino acid alignment of one subunit from each of the seven ble deformities of the digits to very prominent facial dys-
members of the inward rectifying K1 channels. The mutation is de-
morphisms (Figure 1). Cardiac manifestations includednoted above the alignment. Lowercase letters denote conservative
asymptomatic LQT, ventricular ectopy, bi-directional ven-amino acid changes, whereas a “.” denotes a nonconservative
amino acid change. tricular tachycardia, syncope, recurrent torsades de
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pointes, and cardiac arrest requiring treatment with an im-
plantable defibrillator. Attacks of paralysis were associ-
ated with hypo-, hyper-, or normokalemia. Although serum
potassium levels during attacks differed among kindreds,
they were consistent within an individual kindred.
An Andersen’s Syndrome Allele Is Located on
Chromosome 17q23
Approximately 400 polymorphic markers were analyzed
across the entire genome in 15 individuals of kindred
4415 to identify the Andersen’s locus (Figure 2A). Individu-
als were classified as affected in this analysis if they ex-
hibited one of the three main characteristics of Andersen’s
syndrome (periodic paralysis,cardiac arrhythmias, and dys-
morphic features). One marker (D17S949) from the set of
Figure 3. Structure of Kir2.1 and Inward Rectifying K1 Channels400 maximized at u 5 0 with a LOD score of 3.23. The
The locations of identified Andersen’s syndrome mutations are rep-simulated maximum LOD score for this kindred for a
resented on the structure.5-allele system was 3.21 at u 5 0. Marker D17S787 set
the proximal recombinant boundary, whereas D17S784
set the distal recombinant boundary. This region corre-
Kir2.1 mutations and those without a definable mutation.sponds to a genetic region of over 40 cM on chromo-
The mutations occur at highly conserved residues (Fig-some 17q23.
ure 5). Seven of the nine mutations are missense muta-
tions consisting of the following changes (numbering isKCNJ2, CACNG1, and SCN4A Are Candidate
based on KCNJ2 sequence with GenBank accessionGenes for Andersen’s Syndrome
number AF153819): D71V (A440T), S136F (T635C),To identify putative candidate genes located within our
G144S (G658A), R218W (C880T), R218Q (G881A), G300Vlinked region, we examined the mapviewer database
(G1127T), and E303K (G1135A). Two mutations are in-from the National Center for Biotechnology Information
frame deletions: D95–98 (bp 513–524) and D314–15 (bpwebsite. Previous findings that periodic paralysis and
1167–1172). All substitution mutations were checked inLQTS were associated with mutations in ion channels
over 100 unaffected unrelated individuals by SSCP orled us to predict that the AS gene also encoded an ion
mutation-specific PCR analysis (Table 1) and were notchannel. Chromosome 17q23 contigs contained three
found in this panel. R218W occurred in four families,ion channel genes within our linked region, Kir channel
and G300V is present in two families. All other mutationsKCNJ2, calcium channel CACNG1, and sodium channel
were only identified in single families. At least threeSCN4A. Because SCN4A had already been shown to
of the changes represent de novo mutations (G144S,be responsible for periodic paralysis without heart or
R218W (three events), and D314–15). Only one polymor-developmental problems (Ptacek et al., 1991), and the
phism was identified in AS probands. This polymor-CACNG1 gene product is not detected in heart, KCNJ2
phism is a silent mutation of C1374T in the codon forwas examined first. Due to the known function and ex-
residue L382.pression pattern of Kir2.1, KCNJ2 was considered an
The mutations are located throughout the proteinexcellent candidate gene for Andersen’s syndrome.
(Figure 3). D71V resides in the N terminus in the last
position of a predicted a helix. This residue is just distalD71V Segregates with Andersen’s Syndrome
to the putative N-terminal interaction domain (TuckerThe coding region of KCNJ2, contained within one exon,
and Ashcroft, 1999). Deletion D95–98 removes four resi-was PCR amplified and sequenced in all individuals from
dues of the M1 transmembrane segment. This mightkindred 4415 from whom DNA was available. This ex-
completely prohibit the M1 segment from being insertedcludes the deceased individual in the first generation.
into the membrane. S136F and G144S are both poreAn A to T transversion corresponding to the D71V muta-
mutations. G144S is located in the first position of thetion was identified in all affected individuals but not in
highly conserved K1 channel signature sequence GYG.any unaffected family members (Figures 2A, 2B, and 3).
Several mutations reside in the C terminus. R218W andThis mutation was not found in 100 unaffected and unre-
R218Q are located within the C-terminal interaction do-lated individuals.
main (Tinker et al., 1996), and G300V, E303K, and D314-
15 are located in a region of unknown function.Eight Additional Mutations Have Been Identified
in Andersen’s Syndrome Probands
We subsequently examined 15 additional unrelated AS D71V and R218W Mutations Cause Loss of
Function and Result in a Dominant Negativeprobands for mutations in KCNJ2 (Figure 4). As with kin-
dred 4415, the coding region of KCNJ2 was PCR ampli- Effect in Kir2.1
The ability of mutant Kir2.1 subunits to form functionalfied and sequenced. In total, 9 mutations were identified
in 13 probands (Figures 4 and 5). Three of the 16 families homomultimeric channels was assessed by comparing
oocytes injected with wild-type (WT) or mutant Kir2.1examined did not have any mutations in the coding re-
gion of KCNJ2. No discernible difference was observed cRNA (23 ng/oocyte). Injection of WT Kir2.1 induced
nearly instantaneous K1 currents that demonstratedin the clinical manifestations between kindreds with
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Figure 4. Additional AS Kindreds with Identi-
fied Mutations in Kir2.1
Females are denoted with circles and males
with squares. The kindred number and muta-
tion are denoted above each pedigree. De
novo mutations occurred in kindreds 3856,
2679, 6515, 2681, and 5768. “Unknown” indi-
viduals are those for whom we have no clini-
cal data.
strong inward rectification (see Supplemental Figures KCNJ2 allele. To assess the ability of mutant Kir2.1 sub-
units to form functional heteromultimeric channels withS1 and S2 at http://www.cell.com/cgi/content/full/105/
4/511/DC1), as previously described (Raab-Graham et WT subunits, we coinjected mutant (11.5 ng/oocyte) and
WT Kir2.1 cRNA (11.5 ng/oocyte) and compared currentsal., 1994). Inward rectification refers to the property that
permits inward flux of K1 ions at potentials negative to to those induced by injection of WT Kir2.1 cRNA (23 ng/
oocyte). Coexpression of WT and D71V Kir2.1 subunitsthe K1 equilibrium potential (EK) more readily than out-
ward flux at potentials positive to EK. D71V and R218W induced an inwardly rectifying K1 current whose current
amplitude was markedly reduced (Figure 6A). Currentmutant subunits failed to form functional homomul-
timeric channels. Injection of D71V or R218W cRNA did amplitude at 2150 mV was 24.61 6 0.37 mA for WT
Kir2.1, compared to 20.26 6 0.02 mA for coinjectednot induce detectable K1 currents (Figure 6). Small en-
dogenous currents, identical to those in H20-injected WT and D71V. Assuming equal protein expression and
random association of WT and mutant Kir2.1 subunits,control oocytes, were recorded in oocytes injected with
mutant cRNA (see Supplemental Figures S1 and S2 on 1/16 of the channels will be comprised of four WT sub-
units, whereas 15/16 of channels will contain one orCell website).
AS is an autosomal-dominant disorder and, as such, more mutant subunits. The reduction in current induced
by coexpression of WT and D71V subunits was approxi-affected individuals possess one normal and one mutant
Figure 5. Mutations of Kir2.1 in Andersen’s Pa-
tients Occur in Highly Conserved Residues
Chromatographs of the nucleotide sequence
corresponding to each mutation are shown.
*Nucleotide sequence shown is the reverse
complement of coding sequence. Below each
chromatograph is an alignment of the first
member of all human Kir families. Mutant resi-
dues are denoted above each alignment. “D”
marks a deletion of the residue below it. Low-
ercase letters denote conservative amino
acid changes, whereas a “.” denotes a non-
conservative amino acid change.
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Table 1. Primer Sequences and Mutational Analysis Conditions
Mutation Primer Sequence Method Ta
D71V F 59 GGCAACGGTACCTCGCAGA 39 MSP 628C
M 59 GGGAACGATACCTCGCAGT 39
R 59 CAACCAAAACACACAGCCAAA 39
S136F F 59 CGGCTGCCTTCCTCTTCTC 39 MSP 648C
M 59 CGGGTGCCTTCCTCCTCTT 39
R 59 GTTTCTCTTCTTTGGCTTTGC 39
G144S* F 59 GCTTCACGGCTGCCTTCC 39 SSCP 558C
R 59 GTTTCTCTTCTTTGGCTTTGC 39
R218Q F 59 GGCGAGTGGGCAATCTTCG 39 MSP 628C
M 59 GGCGAGTAGGCAGTCTTCA 39
R 59 CTCAAATCATATAAAGGACTGTC 39
R218W F 59 GGCGAGTGGGCAATCTTCG 39 MSP 578C
M 59 GTCGCGAGTAGGCAATGTTT 39
R 59 CTCAAATCATATAAAGGACTGTC 39
G300V* F 59 AGGACATTGACAACGCAGAC 39 SSCP 558C
R 59 CATGGCAGTGGCTTCCACC 39
E303K F 59 CATACTGGAAGGCATGGTGG 39 MSP 638C
M 59 CATGCTGGAAGGAATGGTGA 39
R 59 GTTTTGTGGAACCTGGAATAG 39
“Ta” refers to the PCR annealing temperature. Visualization of PCR products was by 1% agarose gel electrophoresis except where denoted
by an “*” next to the mutation. These exceptions were visualized using standard SSCP techniques. See “Mutational Analysis” in the Experimental
Procedures section. MSP is mutation-specific PCR.
mately 15/16 that of WT current, suggesting that one mu- Discussion
tant D71V subunit is sufficient to eliminate channel func-
tion. Coexpression of WT and R218W Kir2.1 also in- Mutations in Kir2.1 cause the phenotypes of Andersen’s
syndrome, including periodic paralysis, cardiac arrhyth-duced inwardly rectifying K1 currents (see Supplemental
Figure S1 on Cell website), although the magnitude of mias, and dysmorphic features. This conclusion is based
on several findings. (1) An Andersen’s gene is locatedcurrent reduction was not as much as that seen with
D71V subunits (Figure 6). Current amplitudes at 2150 on chromosome 17q23 near KCNJ2. (2) We identified a
mutation D71V cosegregating with the Andersen’s phe-mV were 27.14 6 1.18 mA, 23.80 6 0.66 mA, 21.65 6
0.13 mA, and 20.14 6 0.01 mA for WT Kir2.1 (23 ng/ notype in kindred 4415. (3) An additional eight mutations
were identified in unrelated Andersen’s probands. All mu-oocyte), 1/2 WT (11.5 ng/oocyte), coinjected WT and
R218W, and R218W alone, respectively. These findings tations occur at highly conserved amino acids and in-
clude deletion, substitution, and de novo mutations. Nonedemonstrate that D71V and R218W subunits coassem-
ble with WT Kir2.1 subunits and cause variable degrees of the missense mutations were seen in over 100 unaf-
fected, unrelated individuals. (4) Finally, electrophysio-of dominant negative suppression of channel function.
Figure 6. Functional Effects of D71V and R218W KCNJ2 Mutations
(A) Instantaneous current-voltage relationships for oocytes injected with WT (filled squares), D71V (open triangles), and coinjected WT and
D71V (filled circles) KCNJ2. Currents were elicited by step depolarizations from 2150 to 0 mV, from a holding potential of 270 mV. No
detectable K1 currents were observed following injection of D71V alone, while coinjection of WT and D71V induced small, inwardly rectifying
K1 currents.
(B) Instantaneous current-voltage relationships for oocytes injected with WT (filled squares), 1/2 WT (down triangles), R218W (up triangles),
and coinjected WT and R218W (filled circles) KCNJ2. Injection of R218W alone failed to induce detectable K1 currents. Oocytes were injected
with 23 ng total cRNA, with the exception of 1/2 WT that was injected with 11.5 ng WT cRNA. Currents induced by injection of 11.5 ng WT
were approximately one-half that induced by 23 ng WT Kir2.1. Data represents mean 6 SEM, n 5 8–10 oocytes each group.
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logical data on two of the mutations (D71V and R218W) Dominantly inherited LQTS is due to mutations in the
cardiac Na1 channel (SCN5A) (Wang et al., 1995) orshow that these mutations cause a dominant negative ef-
mutations in subunits encoding the cardiac delayed rec-fect on channel function when coexpressed with wild-type
tifier K1 channels (HERG, KCNQ1, and KCNE1) (Curran etsubunits as assayed by voltage-clamp experiments.
al., 1995; Sanguinetti et al., 1995; Splawski et al., 1997;
Wang et al., 1996). The common pathophysiological fea-Kir2.1
ture of LQTS is prolongation of the cardiac action poten-Kir channels contribute to cell excitability and resting
tial due to either enhanced depolarizing current (Na1membrane potential in excitable tissues including heart,
channel mutations) or reduced repolarizing current (K1brain, and skeletal muscle (Doupnik et al., 1995; Jan
channel mutations). This study identifies KCNJ2 as anand Jan, 1997; Nichols and Lopatin, 1997). Kir channels
LQTS gene and underscores the importance of Kir2.1consist of an intracellular N-terminal domain, two trans-
in modulating cardiac excitability. Kir2.1 was postulatedmembrane segments (M1 and M2) flanking a pore re-
to play an important, but not exclusive, role in generationgion, and an intracellular C-terminal segment (Figure 3).
of the cardiac inward rectifier current (IK1) (Nakamura etKir subunits are believed to form either homo- or hetero-
al., 1998; Wible et al., 1995). IK1 contributes significanttetramers (Yang et al., 1995).
repolarizing current during the terminal phase of the car-Kir2.1 is expressed predominantly in heart, brain, and
diac action potential and serves as the primary conduc-skeletal muscle (Kubo et al., 1993; Raab-Graham et al.,
tance controlling the diastolic resting membrane poten-1994). The function of Kir2.1 has been studied primarily
tial (Em) in atrial and ventricular myocytes (Sanguinettiin the heart. It is classified as a strong inward rectifier,
and Tristani-Firouzi, 2000). Reduction of Kir2.1 functionwhich means that almost no current passes through
would be expected to prolong the cardiac action poten-these channels at potentials positive to 240 mV. Thus,
tial and QT interval in affected individuals by reducingstrong inward rectification prevents excess loss of K1
the amount of repolarizing current during the terminalduring the plateau phase of the cardiac action potential,
phase. Action potential prolongation is a prerequisite forbut allows outward K1 flux during terminal repolarization
early afterdepolarizations (EADs), a presumptive triggerand diastolic phases of the action potential (Sanguinetti
for ventricular tachycardia (January and Riddle, 1989).and Tristani-Firouzi, 2000). Much less is known about
Whether mutations in Kir2.1 alter the diastolic Em in car-the role of Kir2.1 in other tissues such as the brain and
diomyocytes is not known.skeletal muscle. It is likely that the role of Kir2.1 in skele-
Kir channels play an important, albeit secondary, roletal muscle and neurons is similar to its role in the heart
in controlling resting Em in skeletal muscle (Horowiczby controlling the resting membrane potential and the
and Spalding, 1994). While Kir2.1, 2.2, and 2.4 are ex-terminal repolarization phase of the action potential.
pressed in skeletal muscle, the relative contribution ofInterestingly, there is some evidence suggesting that
each subfamily member is not known (Kubo et al., 1993;Kir2.1 has additional functional significance besides
Takahashi et al., 1994; Topert et al., 1998). Our data dem-modulating the action potential of neurons and myo-
onstrate the importance of Kir2.1 in modulating skeletalcytes. Kir2.1 knockout mice have a complete cleft of the
muscle excitability. Mutations in Kir2.1 may sufficientlysecondary palate and a slight narrowing of the maxilla
reduce the resting K1 conductance such that Em is(Zaritsky et al., 2000). In the rat, Kir2.1 mRNA is present
shifted in the depolarized direction, toward the equilib-by embryonic day 12 in bone-associated structure of
rium potential of chloride, the primary resting conduc-the head, limb, and body (Karschin and Karschin, 1997).
tance in skeletal muscle (Horowicz and Spalding, 1994).
Depolarization of the cell membrane would inactivate
Andersen’s Syndrome Mutations Involve Na1 channels, making them unavailable for initiation and
Residues in Important Functional Domains propagation of action potentials. This model is consis-
Several lines of evidence suggest that all of the muta- tent with a common feature in hypokalemic periodic
tions we identified could have functional consequences paralysis (HypoPP), that is, reduced Na1 current (Jurkat-
for Kir2.1. First, all of the identified mutations involve Rott et al., 2000; Ruff, 2000; Ruff and Cannon, 2000). In
residues that are very highly conserved across all fami- individuals with HypoKPP caused by mutations in the
lies of the Kir subunits. Second, several mutations lie in L-type Ca21 channel (Ptacek et al., 1994; Fouad et al.,
functionally important domains such as the pore region 1997), reduced availability of Na1 channels is postulated
containing the GYG K1 selectivity filter. Finally, several to be linked to reduced activity of another Kir channel,
mutations in Kir1.1 causing Bartter’s syndrome, a renal KATP (Ruff, 1999; Tricarico et al., 1999).
disorder involving salt-wasting, hypokalemia, and meta- Recently, Abbott et al. (2001) described a missense mu-
bolic acidosis, are in the same residue or similar func- tation in KCNE3 in two families with hyperkalemic peri-
tional domains as our mutations (Derst et al., 1997; Si- odic paralysis (HyperPP). KCNE3 encodes the MinK-
mon et al., 1996). For instance, D74Y in Bartter’s syndrome related peptide 2 (MiRP2) which coassembles with a
is in the equivalent residue of our D71V mutation. voltage-gated K1 channel, Kv3.4, to form a channel com-
plex that contributes to resting Em in cultured skeletal
Dominant Negative Effects on Kir2.1 Function muscle cells (Abbott et al., 2001). Mutant MiRP2-Kv3.4
Have Consequences for Cardiac and Skeletal complexes conduct less outward current than wild-type
Muscle Excitability complexes, resulting in membrane depolarization and
LQTS is a disorder of cardiac myocellular repolarization altered skeletal muscle excitability. Thus, our data and
manifested by prolongation of the interval between the that of others (Ruff 1999; Tricarico et al., 1999; Abbott
onset of ventricular depolarization (QRS complex) and et al., 2001) support the importance of K1 channels in
modulating skeletal muscle excitability.termination of ventricular repolarization (end of the T wave).
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Kir2.1 in Development tations indicate that these amino acid changes result in
dominant negative effects on Kir2.1 current. Additionally,The importance of ion channels in the function of mus-
cle, heart, and brain is indisputable as evidenced by the our findings provide evidence that Kir2.1 plays an impor-
tant role in skeletal and cardiac muscle function. A furtherplethora of mutations found associated with periodic
paralysis, LQT, and epilepsy. However, an intriguing new in-depth electrophysiological study of all Kir2.1 mutations
could provide additional insight into the structure andniche for ion channels in development has just begun
to be recognized, especially with the characterization function of Kir2.1 in cells and could contribute to a bet-
ter understanding of this syndrome. Finally, identifica-of the weaver mouse. A mutation in the pore region of the
G protein-coupled inward rectifier potassium channel tion of Kir2.1 as the Andersen’s syndrome gene extends
the field of human channelopathies of the nervous sys-GIRK2 was found to be associated with the defects in
neural development of weaver (Patil et al., 1995). tem and heart, and dramatically underscores the similar-
ities among these seemingly disparate episodic disorders.Our findings in AS and Kir2.1 support the link between
this ion channel and developmental processes. Ander-
Experimental Proceduressen’s syndrome and the Kir2.1 knockout mouse both
provide evidence that Kir2.1 might play a previously
Identification and Phenotyping of Patientsunrecognized role in this process. Developmental char-
There are no published clinical criteria for the diagnosis of Ander-
acteristics of the Kir2.1 knockout mouse, including nar- sen’s syndrome. The criteria used were based on the clinical data
rowing of the maxilla and complete cleft of the second- gathered from the three largest published case series (Canun et al.,
1999; Sansone et al., 1997; Tawil et al., 1994). These criteria take intoary palate (Zaritsky et al., 2000), are a potential analogy
account the clinical observation that Andersen’s syndrome showsto the facial dysmorphology seen in many Andersen’s
variable penetrance. Individuals were classified as affected if twopatients. A study of Kir2.1 mRNA expression in rat em-
of three of the following criteria were met: clearcut episodes ofbryos at embryonic day 12 shows that Kir2.1 mRNA is
muscle weakness, cardiac involvement, and dysmorphology. Mus-
associated with bone structures in the head, limbs, and cle weakness was based on one of the following criteria: (1) a typical
body (Karschin and Karschin, 1997). Whether or not history of weakness with rest following exertion or prolonged rest,
(2) an atypical history but with a documented physical exam duringKir2.1 is expressed early enough for craniofacial and
an attack demonstrating hyporeflexia with preserved sensation, (3)other bone morphogenetic events is currently being in-
an atypical history without a documented exam but with unexplainedvestigated. These studies could enhance our under-
intraictal serum hypo/hyperkalemia, or (4) an atypical history withoutstanding of the putative role that Kir2.1 plays in craniofa-
a documented exam or serum potassium levels but with an abnormal
cial and skeletal morphogenesis. exercise nerve conduction study (McManis et al., 1986). Cardiac
involvement was determined by the presence of prolonged QTc on
twelve-lead ECG according to standard criteria (Martin et al., 1995;Variable Expressivity of Andersen’s Syndrome
Schwartz et al., 1993). Dysmorphology was noted if there was theAndersen’s syndrome is incompletely penetrant and
presence of two or more of the following: (1) low set ears, (2) hyper-variably expressed. Severity ranges from nonpenetrant
telorism, (3) small mandible, (4) clinodactyly, or (5) syndactyly (per-
gene carriers (4 of 28 affected individuals), 1 of 3 charac- sistent webbing between fingers). At risk individuals expressing one
teristics (5 of 28), 2 of 3 characteristics (6 of 28), to of the three major phenotypes of Andersen’s syndrome were classi-
severely affected with 3 out of 3 characteristics (13 fied as “probably affected.” Individuals were classified as unaffected
if none of the criteria were fulfilled. One of the authors (R.T.), whoof 28). Variation in expression of alleles, genetic back-
was blinded to the results of the mutational analysis, reviewed theground, or environmental factors could explain such
clinical information on each subject and confirmed their diagnosticpleiotropy. Because of the variable expressivity, it is
classification.
likely that some Andersen’s patients are diagnosed as
LQTS or periodic paralysis patients instead. Genotypic and Linkage Analyses
An automated genome-wide screen was performed on 15 individu-
als in kindred 4415 (Figure 2A) using the ABI marker index of 400Andersen’s Syndrome Is Probably a
polymorphic markers. Markers were distributed across the genomeHeterogeneous Disorder
at z10–20 cM intervals. The fluorescently labeled markers wereWhile data presented in this paper demonstrate that
used to amplify genomic DNA in total reaction volumes of 20 ml inKCNJ2, encoding Kir2.1, is an Andersen’s syndrome gene,
an MJR PTC-200 thermocycler (MJ Research). The products were
we also provide evidence suggesting genetic heteroge- visualized on an Applied Biosystems Model 373A and analyzed by
neity. No mutations in Kir2.1 coding sequence were de- the Genotyper peak-calling software. Pairwise linkage analysis was
performed using the MLINK program of the LINKAGE packagetected in three Andersen families. One possibility is that
(Lathrop et al., 1985). Disease penetrance was set at 0.95 withoutthese families have mutations in the regulatory regions
a gender difference, and the normal and disease allele frequenciesof Kir2.1. An alternative hypothesis is that mutations in
were set at 0.999 and 0.001, respectively.an unidentified partner or regulatory protein of Kir2.1
could also result in AS. Additional candidates for an AS
Mapping
gene are the other members of the Kir 2.x family (Kir2.2, The region of chromosome 17q23 defined by the obligate recombi-
2.3, and 2.4). These other subunits have overlapping nant boundaries of proximal marker D17S787 and distal marker
D17S784 was examined in the mapviewer database (http://www.expression patterns with Kir2.1 in the brain, heart, and
ncbi.nlm.nih.gov/genome/guide/). Candidate genes were selectedskeletal muscle (Morishige et al., 1994; Takahashi et al.,
based on their location within these boundaries as ascertained from1994; Topert et al., 1998). Alternatively, mutations in com-
the available physical map.pletely unrelated genes could be responsible for Ander-
sen’s syndrome in the three unexplained families.
Mutational Analysis
In summary, we have shown that mutations in the The entire coding region of Kir2.1 was amplified (z1.6 kb) from
Kir2.1 gene, KCNJ2, are responsible for Andersen’s syn- genomic DNA in all individuals from kindred 4415. PCR primer se-
quence is as follows: F1 59 CCAAAGCAGAAGCACTGGAG 39 anddrome. Our electrophysiological data on two of the mu-
Cell
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R1 59 AATCAAATACCCAACCAAGGC 39. 50 ml PCR reactions were mV increments to potentials ranging from 2150 to 0 mV from a
holding potential of 270 mV.performed on 100 ng of genomic DNA and 20 pmol of each F1 and
R1 PCR primers using Clonetech’s Advantage-GC cDNA polymer-
ase and buffers. The GC-melt mix was used at a final concentration Data Analysis
Digitized data were analyzed offline using pCLAMP8 and ORIGIN 61.0 mM, and reactions were cycled under the following protocol:
948C–2 min, (948C–10 s, 608C–20 s, 688C–2 min) 3 45, 688C–2 min (Microcal Inc.) software. Peak instantaneous current was measured
after settling of the capacitance transient. Data are expressed asand 30 s, 48C–hold. These products were prepared using the Qia-
quick PCR spin prep kit (Qiagen) and were sequenced using the mean 6 SE (n 5 number of oocytes).
following primers: F1, R1, F2 59 GTGTTTGATGTGGCGAGTGG 39
and R2 59 ATTCCACTGTCAAACCCAAC 39. Sequencing was per- Acknowledgments
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